Assembly Biosciences, Inc.
ASMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426800
No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Assembly Biosciences, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +4 vs. Q2 2024
- Shares held
- 1.03M
- −71.0K (−6.5%) vs. Q2 2024
- Total value
- $15.5M
- +$490.1K (+3.3%) vs. Q2 2024
- New holders
- 5
- 8 more added
- Sold out
- 1
- 7 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASMB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 92 | $514.8M |
| Q1 2026 | 75 | $376.4M |
| Q4 2025 | 69 | $466.7M |
| Q3 2025 | 57 | $324.9M |
| Q2 2025 | 33 | $57.0M |
| Q1 2025 | 37 | $30.4M |
| Q4 2024 | 35 | $50.3M |
| Q3 2024 | 30 | $15.5M |
| Q2 2024 | 27 | $16.1M |
| Q1 2024 | 24 | $8.61M |
| Q4 2023 | 45 | $7.09M |
| Q3 2023 | 32 | $8.44M |
| Q2 2023 | 32 | $12.0M |
| Q1 2023 | 38 | $10.1M |
| Q4 2022 | 40 | $18.4M |
| Q3 2022 | 50 | $27.2M |
| Q2 2022 | 54 | $36.1M |
| Q1 2022 | 54 | $39.3M |
| Q4 2021 | 62 | $53.8M |
| Q3 2021 | 65 | $79.0M |
| Q2 2021 | 91 | $105.1M |
| Q1 2021 | 107 | $133.6M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Assembly Biosciences, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Financial Advisors, LLC | 1 | $16 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 55 | $833 | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 71 | $1.00K | 0.00% | +71 | New |
| Advisor Group Holdings, Inc. | 187 | $2.83K | 0.00% | +187 | New |
| Rhumbline Advisers | 190 | $2.88K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 344 | $5.21K | 0.00% | +298+647.8% | Added |
| Tower Research Capital LLC (TRC) | 588 | $8.90K | 0.00% | −192−24.6% | Reduced |
| GWM Advisors LLC | 762 | $11.5K | 0.00% | +762 | New |
| UBS Group AG | 1,301 | $19.7K | 0.00% | −1,648−55.9% | Reduced |
| Morgan Stanley | 2,660 | $40.3K | 0.00% | +98+3.8% | Added |
| Barclays PLC | 3,035 | $46.0K | 0.00% | +41+1.4% | Added |
| JPMorgan Chase & Co | 3,509 | $53.1K | 0.00% | +3,442+5,137.3% | Added |
| Amundi | 7,934 | $114.4K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 9,016 | $136.5K | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 12,720 | $192.6K | 0.00% | −26−0.2% | Reduced |
| Marshall Wace, LLP | 12,725 | $192.7K | 0.00% | +12,725 | New |
| State Street Corp | 12,809 | $193.9K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 13,558 | $203.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 14,500 | $219.5K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 15,855 | $240.0K | 0.00% | +3,635+29.7% | Added |
| Susquehanna International Group, LLP | 15,857 | $240.1K | 0.00% | −1,543−8.9% | Reduced |
| Federated Hermes, Inc. | 25,394 | $384.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 29,824 | $451.5K | 0.00% | +18,257+157.8% | Added |
| Millennium Management LLC | 37,553 | $568.6K | 0.00% | −85,905−69.6% | Reduced |
| Geode Capital Management, LLC | 47,034 | $712.3K | 0.00% | −7,375−13.6% | Reduced |
| Acuitas Investments, LLC | 62,315 | $943.4K | 0.42% | +12,319+24.6% | Added |
| Renaissance Technologies LLC | 65,624 | $993.5K | 0.00% | +10,713+19.5% | Added |
| BlackRock, Inc. | 77,108 | $1.17M | 0.00% | +77,108 | New |
| Vanguard Group Inc | 200,458 | $3.03M | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 354,000 | $5.36M | 0.14% | −114,000−24.4% | Reduced |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |